NCT06966232View on ClinicalTrials.gov

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

PHASE3RecruitingINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 15, 2027

Study Completion Date

May 20, 2027

Conditions

Gastrointestinal Cancers

Interventions

DRUG

Entecavir

anti hepatitis B virus

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER